Adam Koppel, Director, 10% Owner at Cerevel Therapeutics Holdings, Inc. (CERE), bought 59,961,943 shares at $10.00 ($100.0M) on 2020-10-27, disclosed to the SEC on 2020-10-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 49,961,943 | $0 | 0.0% |
| 2 | $10.00 | 10,000,000 | $100.0M | 100.0% |
| Total | $1.67 avg | 59,961,943 | $100.0M | 100% |
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |